- Home
- KNX vs RYTM Comparison
KNX vs RYTM Comparison
Compare KNX & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNX
- RYTM
- Stock Information
- Founded
- KNX 1989
- RYTM 2008
- Country
- KNX United States
- RYTM United States
- Employees
- KNX N/A
- RYTM N/A
- Industry
- KNX Trucking Freight/Courier Services
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- KNX Industrials
- RYTM Health Care
- Exchange
- KNX Nasdaq
- RYTM Nasdaq
- Market Cap
- KNX 6.4B
- RYTM 6.4B
- IPO Year
- KNX 1994
- RYTM 2017
- Fundamental
- Price
- KNX $47.10
- RYTM $110.20
- Analyst Decision
- KNX Strong Buy
- RYTM Strong Buy
- Analyst Count
- KNX 17
- RYTM 13
- Target Price
- KNX $53.00
- RYTM $110.38
- AVG Volume (30 Days)
- KNX 4.2M
- RYTM 578.6K
- Earning Date
- KNX 10-22-2025
- RYTM 11-04-2025
- Dividend Yield
- KNX 1.53%
- RYTM N/A
- EPS Growth
- KNX 148.62
- RYTM N/A
- EPS
- KNX 1.02
- RYTM N/A
- Revenue
- KNX $7,427,259,000.00
- RYTM $156,287,000.00
- Revenue This Year
- KNX $2.33
- RYTM $46.14
- Revenue Next Year
- KNX $6.28
- RYTM $63.37
- P/E Ratio
- KNX $46.36
- RYTM N/A
- Revenue Growth
- KNX N/A
- RYTM 53.55
- 52 Week Low
- KNX $36.69
- RYTM $45.91
- 52 Week High
- KNX $61.51
- RYTM $113.91
- Technical
- Relative Strength Index (RSI)
- KNX 65.62
- RYTM 69.35
- Support Level
- KNX $42.39
- RYTM $97.97
- Resistance Level
- KNX $46.10
- RYTM $113.91
- Average True Range (ATR)
- KNX 1.61
- RYTM 3.77
- MACD
- KNX 0.65
- RYTM 1.20
- Stochastic Oscillator
- KNX 95.23
- RYTM 79.43
About KNX Knight-Swift Transportation Holdings Inc.
Knight-Swift is the largest full-truckload carrier in the US, with a diversified transportation offering. Pro forma for the US Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.